The experimental study of antihypoxic and antioxidant indolinoren activity
Keywords:indolinoren, antihypoxic activity, antioxidant activity, mexidol, ionol
Topicality. The modern medicine prefers the diuretics, which along with the diuretic effect exhibit other pharmacological activities: e.g., anti-inflammatory, antispasmodic, antioxidant, antihypoxic, which complements their pharmacodynamics.
Aim. To study the antihypoxic investigation and antioxidant activities of the new potential diuretic substance – indolinoren.
Materials and methods. The investigation of an antihypoxic activity was conducted on nonlinear white male rats with weight of 180-200 g using the on the model of hypoxia with hypercapnia. The antioxidant activity research was carried out in vitro using the system model of yolk lipoprotein. As reference drugs mexidol and ionol were used.
Results and discussions. It was established that indolinoren at dose of 29.5 mg/kg reveals antihypoxic properties, as evidenced by a significant extension (2 times) of lifespan of animals compared to the control group. While studying the antioxidant properties it was found that indolinoren significantly reduces the accumulation of TBA-reactive products taken in all experimental doses (50, 100, 200 mg/ml) that may indicate suppression of lipid peroxidation.
Conclusions. The presence of antioxidant and antihypoxic properties complement pharmacodynamics of indolinoren – perspective diuretic agent.
Zverev, Ya. F. (2000). Farmakologiia i klinicheskoe ispolzovanie ekstrarenalnogo deistviia diuretikov. Мoscow: Med. kniga, Nizhnii Novgorod: NGMA, 256.
Belovol, A. N., Georgiiantc, V. A., Gladchenko, O. M. et al. (2005). Lekarstvennye preparaty Ukrainy. Kharkiv: NUPh: Zolotye stranitcy, 512.
House, A. A., Haapio, M., Lassus, J. et al. (2010). Diuretic resistance as an indicator of ultrafiltration in patients with cardiorenal syndrome. Am. J. Kidney Dis, 56 (4), 759–773.
Yamada, H., Mishiro, Y., Kusunose, K., Sata, M. (2010). Effects of Additional Administration of Low–Dose Indapamide on Patients With Hypertension Treated With Angiotensin II Receptor Blocker. Journal of Cardiovascular Pharmacology and Therapeutics, 15 (2), 145–150. doi: 10.1177/1074248410361336
Zhyrov, I.V. (2012). Russkii meditcinskii zhurnal, 20 (25), 1298–1302.
Mareev, V. Yu., Ageev, F. T., Arutiunov, G. P. et al. (2010). Serdechnaia nedostatochnost, 11 (57), 253–254.
Amosova, E. N. (2010). Sertse i sudyny, 3, 15–16.
Leonova, M. V. (2015). Consilium Medicum, 23–26.
Khomaziuk, T. A. (2011). Arterialnaia gipertenziia, 6, 76–80.
Mashkovskii, M. D. (2002). Lekarstvennyie sredstva, 14–e izd. Moscow: Novaia Volna, 82–86, 476–480.
Ivanov, D. D. (2008). Zdorovia Ukrainy, 1 (11), 80–81.
Kobalava, Zh. D., Kotovskaia, Yu. V., Troitckaia, E. A. (2010). Russkii meditcinskii zhurnal, 3, 99-103.
Drogovoz, S. M., Gudzenko, A. P., Butko, Ya. O. et al. (2010). Pobochnoe deistvie lekarstv. Kharkiv: SIM, 480.
Markina, A. Yu., Tiupka, T. I. (2013). Vestnik KAZNMU, 5 (1), 163–165.
Sernov, A. N., Gatcura, V. V. (2000). Elementy eksperimentalnoi farmakologii.Moscow: Meditcina, 352.
Kozhemiakin, Yu. M., Khromov, O. S., Filonenko, M. O., Saifetdinova, H. A. (2002). Naukovo–praktychni rekomendatsii z utrymannia laboratornukh tvaryn ta roboty z nymy. Kyiv: Avitsenna, 156.
Lapach, S. N., Chubenko, A. V. Babych, P. N. (2000). Statisticheskie metody v mediko–biologicheskih issledovaniiah s ispolzovaniem EXEL.Kiev: MORION, 320.
Marshal, V. Dzh. (2002). Klinicheskaia biohimiia.Moscow – Sankt– Peterburg: BINOM – Nevskii Dialekt, 408.
Makovetskyi, V. P., Maksin, V. I., Kurapova, T. M. et al. (2010). Bioresursy i pryrodokorystuvannia, 1 (2), 7–11.
Menshikova, E. B., Lankin, V. Z., Zenkov, N. K. et al. (2008). Okislitelnyi stress: patologicheskie sostoianiia i zabolevaniia. Novosibirsk : ARTA, 284.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).